Robert Brenner serves as Chief Medical Officer at Vera Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Robert Brenner has executed 3 insider transactions totaling $90.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 23, 2026 involved selling 2,151 shares valued at $90.3K.
Robert Brenner currently holds 50,947 shares of Vera Therapeutics, Inc. (VERA), valued at approximately $0. This represents their equity stake as Chief Medical Officer.
Based on SEC Form 4 filings, Robert Brenner has been a net seller of VERA stock. They have purchased $0 and sold $90.3K worth of shares.
Robert Brenner's most recent insider trade was on Feb 23, 2026, when they sold 2,151 shares at $41.98 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 4, 2026 | VERA | $0 | Award | 25,000 | $N/A | Discretionary |